...

CCO Treatment Updates

A Call to Action: Preventing Bone Loss and Skeletal-Related Events in Patients With Prostate Cancer: Highlights From the Symposium

Slideset Module

A Call to Action: Preventing Bone Loss and Skeletal-Related Events in Patients With Prostate Cancer: Highlights From the Symposium

Program Director: Matthew R. Smith, MD, PhD

Faculty: Celestia S. Higano, MD, FACP, Gregory R. Mundy, MD, Joel Byron Nelson, MD

CREDIT INFORMATION

Release Date: 06/15/09

Expiration Date: 06/14/10


Physicians: maximum of 0.75 AMA PRA Category 1 Credits™

Status: Please log in to view status
Begin the CCO Slideset

Expert faculty provide an overview of the bone microenvironment, treatment-related bone loss, prevention of metastatic disease, and evolving treatment options for managing bone health in prostate cancer patients.

Learning Objectives

Upon completion of this activity, participants should be able to:

  • Describe the pathophysiology of treatment-related bone loss and bone metastases in patients with prostate cancer
  • Discuss current and novel treatment approaches for patients with prostate cancer who experience treatment-related bone loss and skeletal-related events
  • Summarize clinical trial data on the use of specific therapeutic agents to prevent bone metastases in prostate cancer patients
  • Cite novel molecular targets under investigation for the treatment of skeletal-related events in patients with prostate cancer

Slideset: A Call to Action: Preventing Bone Loss and Skeletal-Related Events in Patients With Prostate Cancer: Highlights From the Symposium

Download the Slideset


Download slides focused on the mechanisms underlying the bone microenvironment and how to best manage bone health and skeletal-related events in prostate cancer patients.


Format: Microsoft PowerPoint (.ppt) | File size: 9.29 MB | Date posted: 6/15/2009


Disclaimer: The materials published on the Clinical Care Options Web site reflect the views of the reviewers or authors of the CCO material, not those of Clinical Care Options, LLC, the CME provider, or the companies providing educational grants. The materials may discuss uses and dosages for therapeutic products that have not been approved by the United States Food and Drug Administration. A qualified healthcare professional should be consulted before using any therapeutic product discussed. Readers should verify all information and data before treating patients or using any therapies described in these materials.

Jointly sponsored by Postgraduate Institute for Medicine and Clinical Care Options, LLC.

Contact Info

Educational grant provided by:

Educational grants support only the CME-certified components of this program.